Literature DB >> 21781013

A look into the future: improving diabetes care by 2015.

Stephen Brunton, Stephen Gough, Debbie Hicks, Jianping Weng, Etie Moghissi, Mark Peyrot, Doron Schneider, Petra Maria Schumm-Draeger, Christine Tobin, Anthony H Barnett.   

Abstract

Insulin initiation, which was traditionally the province of specialists, is increasingly undertaken by primary care. However, significant barriers to appropriate and timely initiation still exist. Whilst insulin is recognized as providing the most effective treatment in type 2 diabetes, it is also widely considered to be the most challenging and time consuming. This editorial identifies that the organization of existing healthcare services, the challenges faced by patients, and the treatments themselves contribute to suboptimal insulin management. In order to improve future diabetes care, it will be necessary to address all three problem areas: (1) re-think the best use of existing human and financial resources to promote and support patient self-management and adherence to treatment; (2) empower patients to participate more actively in treatment decision making; and (3) improve acceptance, persistence and adherence to therapy by continuing to refine insulin therapy and treatment regimens in terms of safety, simplicity and convenience. The principles discussed are also applicable to the successful management of any chronic medical illness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781013     DOI: 10.1185/03007995.2011.603300

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  7 in total

1.  Discrete Choice Experiment Attribute Selection Using a Multinational Interview Study: Treatment Features Important to Patients with Type 2 Diabetes Mellitus.

Authors:  Anna Rydén; Stephanie Chen; Emuella Flood; Beverly Romero; Susan Grandy
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

Review 2.  Identifying and meeting the challenges of insulin therapy in type 2 diabetes.

Authors:  Christopher Sorli; Michael K Heile
Journal:  J Multidiscip Healthc       Date:  2014-07-02

3.  The Influence of National Health Insurance on Medication Adherence Among Outpatient Type 2 Diabetics in Southwest Nigeria.

Authors:  Saka S Ajibola; Fajemirokun O Timothy
Journal:  J Patient Exp       Date:  2017-09-29

4.  When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control.

Authors:  Guillermo E Umpierrez; Neil Skolnik; Terry Dex; Louise Traylor; Jason Chao; Charles Shaefer
Journal:  Diabetes Obes Metab       Date:  2019-03-25       Impact factor: 6.577

5.  Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study.

Authors:  Jean de Dieu Murwanashyaka; Albert Ndagijimana; Emmanuel Biracyaza; François Xavier Sunday; Maryse Umugwaneza
Journal:  BMC Endocr Disord       Date:  2022-08-31       Impact factor: 3.263

6.  Non-adherence in type 2 diabetes: practical considerations for interpreting the literature.

Authors:  David F Blackburn; Jaris Swidrovich; Mark Lemstra
Journal:  Patient Prefer Adherence       Date:  2013-03-03       Impact factor: 2.711

Review 7.  Treat-to-target trials in diabetes.

Authors:  Subhash K Wangnoo; Bipin Sethi; Rakesh K Sahay; Mathew John; Samit Ghosal; Surendra K Sharma
Journal:  Indian J Endocrinol Metab       Date:  2014-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.